Why is zinc acetate dihydrate not recommended as initial therapy for symptomatic Wilson's disease?

Zinc acetate dihydrate (Wilzin) has a slow onset of action, so symptomatic Wilson’s disease requires initial chelation; zinc may initially accompany a chelator while its effect develops, and Wilzin maintenance can be considered once copper is below toxic thresholds and the patient is clinically stable.